Stage IV Adrenocortical Carcinoma
4 clinical trials · Condition
◉ Watch Stage IV Adrenocortical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery (NCT00848016) | National Cancer Institute (NCI) | 2009-02-01 |
| IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery (NCT00778817) | National Cancer Institute (NCI) | 2008-12-01 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074) | National Cancer Institute (NCI) | 1999-08-01 |
| Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer (NCT00003453) | Burzynski Research Institute | 1996-08-21 |
Track Stage IV Adrenocortical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.